News
Banco BTG Pactual SA, Latin America’s largest independent investment bank, agreed to buy HSBC Holdings Plc’s operations in ...
Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as BTG plc ( LON:BTG ), with a market cap of UK£2.01b, often get neglected by retail investors.
To bolster its offerings in interventional medicine, Boston Scientific agreed to purchase British device and pharma firm BTG PLC. for $4.24 billion in cash, according to The Wall Street Journal.
A U.S. unit of British drug company BTG Plc pleaded guilty on Monday to improperly marketing its embolic device LC Bead, and will pay about $36 million to resolve its criminal and civil liability ...
Boston Scientific Corp. BSX 0.67% has agreed to buy British health-care firm BTG PLC for £3.3 billion ($4.24 billion), bolstering its presence in the growing field of interventional medicine ...
LONDON, July 16, 2019 /PRNewswire/ -- BTG International Asia Limited, a subsidiary of BTG plc (LSE: BTG) announced today that it has agreed to invest RMB 76million (approximately USD 11million) in ...
BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Novate Medical Ltd. (“Novate”), a medical device company ...
Shares of BTG PLC (BTG.LN) fell in early trade Friday after the health-care company said that a U.S. Food & Drug Administration panel has voted against the approval of its Elevair Endobronchial ...
Boston Scientific Corp. BSX said Tuesday that it has agreed to a takeover bid for U.K. specialty health-care company BTG PLC (BTG.LN) in a deal worth 3.3 billion pounds ($4.23 billion). The ...
British healthcare company BTG Plc <BTG.L> has acquired Irish medical device maker Novate Medical, adding to its portfolio a vascular device for managing blood clots.
BTG plc is a UK pharmaceutical company specializing in antivenoms, oncology drugs and treatments for varicose veins. BTG's snakebite antivenom, Crofab, has been the most significant contributor to ...
Galil Medical Inc., a developer of cryoablation products for the treatment of kidney and other cancers, has agreed to be acquired by specialist health-care company BTG PLC. BTG will pay $84.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results